Glimnof-M2 Tablet PR belongs to a class of medicines called anti-diabetic drugs used in the treatment of type 2 diabetes, especially in patients whose blood sugar levels are not controlled by diet and exercise alone.

Glimnof-M2 Tablet PR contains Glimepiride and Metformin. Glimepiride helps the pancreas release more insulin, thereby lowering blood sugar levels. Metformin reduces the amount of sugar produced by the liver, slows down sugar absorption from food, and helps the body use insulin more effectively.

In some cases, Glimnof-M2 Tablet PR may cause side effects like stomach pain, nausea, diarrhoea, vomiting, headache or metallic taste. Most of these side effects of Glimnof-M2 Tablet PR do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.

Do not take Glimnof-M2 Tablet PR if you are allergic to any of its components. Glimnof-M2 Tablet PR is not recommended during pregnancy, breastfeeding and in children. Avoid alcohol consumption with Glimnof-M2 Tablet PR as it may increase the risk of lactic acidosis (accumulation of lactic acid in the body).

• Glimnof-M2 Tablet PR can be taken with meals or as prescribed by the doctor.
• Follow your doctor's instructions on the dosage and timing of this medication to ensure safety.
• Swallow Glimnof-M2 Tablet PR as a whole with a glass of water.
• Do not chew, crush or break it.

• Glimnof-M2 Tablet PR is indicated as an adjunct to diet and exercise to improve glycaemic control in patients with type 2 diabetes.
• It helps manage blood glucose levels in patients with diabetes and prevents diabetes-related complications like kidney damage, eye problems, and nerve issues.
• Glimnof-M2 Tablet PR contains Glimepiride and Metformin, which work together to offer a dual-action approach for effectively managing type 2 diabetes.
• Glimepiride stimulates cells in the pancreas that produce insulin, which helps remove sugar from the blood.
• Metformin reduces sugar production by cells in the liver and delays sugar absorption from the intestines. Additionally, it enhances the sensitivity of muscle cells to insulin, allowing these cells to remove sugar more effectively from the bloodstream.

• Do not take Glimnof-M2 Tablet PR if you are allergic to any of its components, if you have type 1 diabetes mellitus, diabetic ketoacidosis or diabetic coma. 
• Inform the doctor if you have liver or kidney problems, low blood sugar, or circulation problems.
• Glimnof-M2 Tablet PR is not recommended for pregnant women as it may harm the unborn baby. Please consult a doctor if you are pregnant or planning to become pregnant. This medicine may pass into breast milk; therefore, it should be avoided in nursing mothers. 
• Glimnof-M2 Tablet PR may decrease alertness in some people. Therefore, drive only if you are alert after taking Glimnof-M2 Tablet PR. 
• Avoid alcohol consumption with Glimnof-M2 Tablet PR as it may increase the risk of lactic acidosis (accumulation of lactic acid in the body).
• Beware of symptoms of hypoglycemia (low blood sugar), which include sweating, dizziness, palpitations, shivering, intense thirst, dry mouth, dry skin, frequent urination, etc. Whenever you experience any of these symptoms, immediately consume candies, glucose biscuits, or honey/sugar. Make sure to carry these with you at all times, especially during long travels.